The organ preservation market is worth $217 million in 2021, and by 2026 it is expected to reach $317 million with a CAGR of 6.6%. The market is growing due to many factors; for instance, multiple organ failures, a growing senior population, organ transplants, organ donor increment, and organ donation initiatives have been significant compared to previous years. In 2018, the US witnessed nearly 36,000 organ transplants; and almost 95% of adults support organ donation. read also about : Goat Halter
Cardiovascular disease is one of the culprits behind the increase in mortality and morbidity rate. Cardiovascular diseases, like coronary artery disease, congenital heart defects, heart failure, and peripheral vascular disease, are prevalent worldwide. American Heart Association report states that nearly 100 million Americans are living with some CVD, and as per statistics, CVD kills more people yearly than any other disease. The report also states that every day 2,300 people die in America due to cardiovascular disease. Such a high death rate will automatically give rise to an increase in heart transplants.
MARKET OPPORTUNITY
The rising number of organ transplantation methodologies across the globe and rising instances of various organ disappointments are the main considerations pushing the market development. As per a report distributed by the Wellbeing Assets and Administrations Organization in 2019, around 36,528 organ transplants were acted in the U.S. in 2018, and around 95.00% of grown-ups in the nation support organ gift. It additionally detailed that around 17,553 contributors were kept in 2018 of which 10,722 were expired givers and 6,831 were living benefactors.
Besides, as per the report distributed by the Chamber of Europe in 2019, 41,000 patients went through organ transplantation in 2018 in Europe. Consequently, such occasions are expect to advance the organ protection market development over the conjecture period.
Cardiovascular Illnesses (CVD) have become one of the significant reasons for mortality and horribleness throughout the course of recent many years. Coronary course infection, arrhythmias, fringe vascular sickness, cardiovascular breakdown, and inborn heart deserts are the major cardiovascular illnesses predominant across the globe. As per the report distributed by the American Heart Relationship in 2018, around 92.1 million Americans are living with a few types of CVD, and CVD is the most well-known cause for mortality in the nation when contrasted with malignant growth and other constant sicknesses.
MARKET TRENDS
It likewise detailed that around 2,300 Americans bite the dust because of cardiovascular infection each day, which is around 1 demise at regular intervals.
As per the report distributed by the Habitats for Infectious prevention and Counteraction (CDC) in 2019, around 15.00% of grown-ups in the U.S. experience the ill effects of persistent kidney sicknesses consistently. Essentially, according to the report distributed by the Public Foundation of Diabetes and Stomach related and Kidney Sicknesses in 2019, around 661,000 Americans experience the ill effects of kidney disappointment, of which 468,000 patients are on dialysis and around 193,000 went through kidney relocation.
As per the information distributed by the Public Community for Biotechnology Data in 2019. Around 2.0 million passings happen because of liver sicknesses each year universally, and around 1.0 million passings happen because of difficulties of lung cirrhosis. It likewise revealed that liver transplantation is the second most relocated organ. Such examples show the impressive development of the market for organ counteraction.
MARKET INSIGHTS
- The kidney transplant rate is expect to rise as cases of kidney failure are on the rise.1 in 3 adults in the US (nearly 80 million) is at risk of kidney disease. Even obesity and heart disease can be contributors to kidney failure. Nearly 786,000 people in the US live with ESKD (End Stage Renal Disease).
- Liver and cirrhosis account for nearly 2 million deaths every year globally.
- Nearly 26%-50% of sepsis patients face acute renal failure, and nearly 20% show signs of acute respiratory failure.
- World Population Ageing report states that people above 65 years of age is nearly 728 million and this figure is expected to be 1.5 billion by 2050, and we are moving towards an increase in the geriatric population which will give rise to more organ transplants as older people are susceptible to various kind of diseases.
RESTRAINT
- Organ transplantation involves a high pay scale for doctors and surgeons; transportation costs and drugs are expensive. The amount associated with organ procurement, inpatient care, anti-rejection medication, and post-operative care increases the overall cost. High cost is the main culprit restricting the organ preservation market growth.
MARKET ANALYSIS OF ORGAN PRESERVATION MARKET SEGMENTS COVERED IN THE REPORT
- Organ Type
- Liver
- Kidney
- Heart
- Lung
- Others
- Preservation Technique
- Hypothermic Machine Perfusion
- Static Cold Storage
- Normothermic Machine Perfusion
- Various others
- Region
- North America
- The U.S.
- Canada
- Europe
- Germany
- The U.K
- Asia Pacific
- Japan
- China
- Latin America
- Mexico
- Brazil
- MEA
- Saudi Arabia
- South Africa
